Thursday | September 10, 2020
Platinum Sponsors
Today at 4.00 - 5.00pm
Join us for the first event of the season to network with members of the life sciences community. We are using the new networking software program Remo which will allow you to move from virtual table-to-table to meet with fellow attendees. This is a great opportunity to make new contacts and learn more about recent developments and projects. 
Event Details
Date: Thursday, September 10, 2020 
Time: 4:00 – 5:00 PM 
Location: Online 
Tickets: Free for LSBC Members & $25 for LSBC Non-Members 

Web page link to event and application

Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that the Company’s Compensation Committee granted 105 new employees non-qualified stock options...READ MORE
Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System
September 8, 2020 – VANCOUVER, British Columbia – Kardium Inc. announced the first commercial procedures with the Globe Mapping and Ablation System. The Globe System is the most complete solution for the treatment of atrial fibrillation (AF) – the world’s most common heart rhythm disorder, affecting more than 37 million people. READ MORE
Neoleukin Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
SEATTLE, Sept. 09, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M.D., Chief Executive Officer...READ MORE
Aurinia Pharmaceuticals to Present at Three Upcoming Virtual Investor Conferences
September 10, 2020, VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the senior management team will participate in fireside chats during the following upcoming virtual investor conferences...READ MORE
Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of Directors
SEATTLE, Sept. 10, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the appointment of Martin Babler, President and Chief Executive Officer of Principia Biopharma, Inc. (NASDAQ: PRNB), to the company’s Board of Directors. READ MORE
The Health and Technology District Partners with Halo Health’s Angel Investor Group of Canadian Physicians
Partnership to scale up and strengthen Canada’s health-tech innovation ecosystem
Surrey, B.C. (September 10, 2020) The Health and Technology District in Surrey, B.C. is partnering with Halo Health, Canada’s first angel network for healthcare, on a new collaboration to expand and support health-tech innovations and entrepreneurs. READ MORE
Manitoba Announces Changes to Senior Ranks of Public Service
The Manitoba government has made changes to the senior ranks of the Manitoba public service with the appointment of new deputy ministers, Premier Pallister announced today. (Editors Note: Tracy Maconachie – named deputy minister of economic development and training former President of Bioscience Association Manitoba) READ MORE
Announcing The 2020 MSFHR Scholars And Research Trainees
Artificial intelligence in breast cancer screening, mental health in immigrant and refugee children, substance use harm reduction, and vaccine education for midwifery clients are just some of the areas being investigated by this year’s MSFHR Scholar and Research Trainee award recipients who are advancing science, addressing health priorities, and improving the health of British Columbians. READ MORE
Biopharma leaders unite to stand with science
The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX), GlaxoSmithKline plc (LSE/NYSE: GSK), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), known as MSD outside the United States and Canada, Moderna, Inc. (Nasdaq: MRNA), Novavax, Inc. (Nasdaq: NVAX), Pfizer Inc. (NYSE: PFE), and Sanofi (NASDAQ: SNY), today announced a historic pledge, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines. READ MORE
Gold Sponsors
Metaphase Health Research Consulting Inc. provides medical and strategic writing services targeted at a specialist audience. They work with Health and Medical Research organizations, Pharmaceutical companies and Medical Communications companies. Metaphase works with specialists to write and submit scientific manuscripts, document strategic or scientific advisory board meetings, conduct literature reviews and create educational materials.

SaNOtize has developed products for chronic sinusitis, diabetic foot ulcers and onychomycosis, two of which are in the clinical trials. Phase II clinical trials to use their nasal spray against the COVID-19 virus are also on-going at sites across Canada. So far, treatment data looks very compelling. SaNOtize’s formulation inactivated more than 99.9% of the SARS-CoV-2 virus within two minutes in the laboratory setting. 

Silver Sponsors
LSBC Job Board
Update: Student Work Placement Program now open to healthcare placements
The Student Work Placement Program is now accepting applications for healthcare placements. Canada’s healthcare industry has a growing need to produce job-ready healthcare workers. There are 1,500 open spots available in 2020-21. WEBSITE
Bronze Sponsors
Posting A JOB on the LSBC Website
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? CONTACT: Sue Callaghan -
LSBC Member Benefits
Membership Benefits Program

As a LifeSciences BC member, organizations and their employees can benefit from significant savings on a range of business and personal services, thanks to our Membership Benefits Program partnerships. You can locate the cost savings program suited to you needs here.